The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers

Eur J Clin Invest. 2002 Mar;32(3):153-7. doi: 10.1046/j.1365-2362.2002.00966.x.

Abstract

Aims: Atherosclerosis is a chronic inflammatory condition, manifest in its early stages by endothelial dysfunction. Interleukin-6 (IL6) plays a key role in driving this process through stimulation of acute phase protein synthesis. We have examined the effect of the IL6 gene -174G > C promoter polymorphism on endothelial function in a group of healthy subjects.

Methods: 248 adults aged 20-28 years participated. Polymerase chain reaction was performed for the -174G > C polymorphism. Brachial artery diameter was measured at rest and after forearm cuff occlusion by high-resolution ultrasound. Responses were represented as absolute flow mediated dilatation (FMDA).

Results: Overall there was a trend towards greater FMDA for genotype CC, P = 0.14. No effect was seen in women; however, in men, following multivariate analysis, there was a significant association between genotype and FMDA, P = 0.04. In addition, a significant detrimental effect of smoking on FMDA was only seen in males of genotype CC (P < 0.05) when compared to nonsmokers of the same genotype.

Conclusion: IL6-174G > C promoter polymorphism influences endothelial function in healthy male subjects. The detrimental effect of smoking on endothelial function is most clearly seen in men of genotype -174 CC, suggesting a genotype-specific interaction with smoking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arteriosclerosis / epidemiology
  • Arteriosclerosis / genetics
  • Arteriosclerosis / immunology
  • Brachial Artery / physiology
  • Endothelium, Vascular / physiology*
  • Female
  • Genotype
  • Humans
  • Interleukin-6 / genetics*
  • Male
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic / genetics*
  • Risk Factors
  • Sex Distribution
  • Smoking

Substances

  • Interleukin-6